BCL2 and benign neoplasm: Considering tumor lesions (78) and apoptotic markers expression (Table 2 and S2 Table), Bcl-2 was more expressed in malignant tumors (P<0.01 for positive cells intensity and IRS scale) than in benign tumors (Fig 1A and 1B) and in healthy tissue.